🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🛎️Back home after #ISTH2024 Lots to think about reflect and catch up within haemostasis and thrombosis and work with ISTH and SSCs. 🛎️Many pictures to post but I still see the one with Luke Blount to be among the best ones 🤩😃

The plans for #ISTH2025 is already underway. With Guy Young Alisa Wolberg and riitta lassila as heads of the ACPC we look forward for a fantastic congress in #WashingtonDC in 2025! youtu.be/nCb2abEJf6k?fe…

Thanks Michelle Sholzberg for advocating for women’s improved quality of Life across the globe!🙏💪😍

💡#VTE is an avoidable cause of harm! #WorldThrombosisDay 💡 Understand thrombosis. 💡 Assess thrombosis risk. 💡 Prevent thrombosis.

🛎️ A meeting not to be missed! 🤩

🛎️Participate in an international ISTH research survey 🛎️ Share your experience with anemia in pregnancy 🛎️Help us assess implications of on the postpartum 🩸& Venous thromboembolism .

Re-visiting the “LOW VWF” 30-50 category and when to consider possible VWD diagnosis! Thanks JTH

Great start to 2025 with the publication of this work lead by Lucy NORRIS in Thrombosis Research! Looking forward to contributing to future studies predicting risk to thrombosis in patients with cancer during chemotherapy thanks to support from HealthResearchBoard shorturl.at/nj8eV

The recent Thrombosis Update paper presents an overview of public involvement as a whole and specifically reflects on how it has added value, to an international cancer associated thrombosis #CAT research. #ThrJournal Read more here: sciencedirect.com/science/articl…

Ridiculous

🎉👏 🤩 ISTH I forward to a fantastic congress in Washington this year💪

Amazing and very well deserved recognition! Congratulations 🎉 Deborah Siegal 👏🤩

It’s Rare Disease Day! Rare diseases are those that affect <200k in the US. Altogether, they affect 30 million in the US & 300 million globally. All pediatric cancers are rare. And >90% of rare diseases have no FDA approved treatment.

In support, here is our latest published issue of STH ("Precision Medicine in Rare Bleeding Disorders"), with content available at lnkd.in/gWAu7jRa.

📢 Upcoming Webinar: Thromboprophylaxis in Pregnant Patients! Join us for an expert-led session exploring best practices and clinical insights on managing thrombosis risk during pregnancy. 📍Register now to save your spot: bit.ly/4lcjcZ2

Patients looking for answers to thrombosis-related questions will find our library of information sheets (27 in total), on topics ranging from understanding their diagnosis to managing their treatment, a valuable place to go. Check out our latest publication on CTEPH (Chronic

Just popping back over to remind you that almost 40% of 12-21 yo females are iron deficient, it’s easy and inexpensive to treat, and most of them have no idea. jamanetwork.com/journals/jama/…

LAST CHANCE TO SAVE ⤵️

Pleasure to interview the brilliant Dr.Marc Carrier at our latest Thrombosis Canada clot conversation podcast Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose ;preventing recurrent VTE in cancer patients while resulting in less bleeding 🩸

Thanks yousra for the shout out. I am so proud of you and all my mentees for your amazing accomplishments. The ISLH 2025 was truly a memorable community and a landmark of success to us all.